The Philippine COVID-19 Living Recommendations document is brought to you by the Institute of Clinical Epidemiology, National Institutes of Health, UP Manila in cooperation with the Philippine Society of Microbiology and Infectious Diseases (PSMID). This was funded by the DOH Ahead Program through the DOST-Philippine Council for Health Research and Development (PCHRD).
Given the magnitude of the impact of COVID-19 in the country and the current priority given to it by clinicians, public health officials and the government, there is the need for clinical practice guidelines to contribute to the effective management and control of the spread of this disease. While there are existing international guidelines and living systematic reviews (LSRs) on COVID-19, there is a need to localize the recommendations from the evidence in our setting by local experts, end-users and other relevant stakeholders. With the rapidly evolving science behind the management of COVID-19, the Living CPG development method will be used wherein recommendations will be switched to a living status based on the likelihood of new evidence and the importance of the recommendation in health care policy decision making. LSRs will be maintained to develop a living CPG that will provide up-to-date, evidence-based guidance on the treatment, diagnosis and infection control of COVID-19. Read more at www.psmid.org